Policies & Procedures
- Informed Consent for Living Donors Policy
- Living Donor Diabetes Screening Algorithm
- Living Donor Multidisciplinary Patient Management Policy
- Living Kidney Donor Program Evaluation Phases
- Living Donor Evaluation Protocol
- Non-Directed Organ Donor Policy
- Independent Donor Advocacy Program Policy
- Social Work Policy
- Living Donor Blood Pressure Algorithm
- Living Donor Kidney Stone Algorithm
- Pharmacy Policy
- Nutrition Policy
- Living Donor Candidate Selection Process
- Policy on Information Sharing Between Living Donors and Recipients
- Financial Guidance for Living Donors Policy
- Living Donor Inclusion and Exclusion Criteria
- Zika Virus and Living Donation Policy
- Living Donor Specimen and Storage Requirements Policy
- Living Donor Follow-up Policy
- Kidney Transplant Multidisciplinary Patient Management Policy
- Policy on Informed Consent for Kidney Transplant Patients
- Process for Evaluating Kidney Transplant Candidates
- Inclusion and Exclusion Criteria for Kidney Transplantation
- Obesity Policy
- Narcotics, Recreational Drug Use and Transplantation Policy
- Pre-transplant Cardiac Evaluation Policy
- Vaccination Policy
- Nutrition Policy
- Wait List Management Policy
- Management of Medically Inactive Waitlisted Patients
- Communication with Patient Care Providers Policy
- Social Work Policy
- Pharmacy Policy
- Hepatitis C Virus (HCV) and Kidney Transplantation
- Kidney Donor Profile Index >85 Policy
- Malignancy Prior to Transplantation Policy
- Referrals for Kidney Transplant Policy
- Inclusion and Exclusion Criteria for Transplant Listing
- Antimicrobial Prophylaxis Policy
- Surgical Drain Protocol
- Ureteral Stent Policy
- Immunosuppression Policy
- Immunosuppressive Drug Level Guidelines
- Rejection Protocol
- Patient and Caregiver Education Policy - Kidney Transplants
- Narcotics, Recreational Drug Use and Transplantation Policy
- Allograft Obstruction Policy, Procedure and Order Set
- Polyoma Protocol
- Anemia Management Policy
- Hepatitis C Virus (HCV) and Kidney Transplantation
- Dyslipidemia and Kidney Transplantation Management Recommendations
- Post-operative Kidney Transplant Ultrasound Policy
- Donor Specific Antibody and Allosure Protocol
- Chronic Kidney Disease - Mineral and Bone Disorder Guidelines
- Coverage Plan
- Program Inactivity, Withdrawal and Termination Policy
- Joint Operating Policy Histocompatibility Strategies for the Maine Transplant Program & NorDx Immunogenetics (HLA) Laboratory
- Kidney Transplant Multidisciplinary Patient Management Policy
- Quality Assurance and Performance Improvement (QAPI) Policy
- Living Donor Quality Assessment and Performance Improvement (QAPI) Policy
- Adverse Event Policy
- New Kidney Allocation Rules
- Kidney Paired Donation Administration Policy
- OPTN Policies- United Network for Organ Sharing
- Memorandum of Understanding - Maine Transplant Program & Pediatric Nephrology
- Storm Preparation Policy
- Identification and Management of Transmissible Diseases Pre and Post Transplantation
- Transplant Patient Assistance Fund Policy
- Transplanting Prisoners Policy
- UNOS Living Donor Forms Completion and Submission
- Vaccination Policy
- Transplant Program Disaster/Emergency Plan
- Selection Criteria for Transplantation and Living Kidney Donation
- Duties of the Medical Director Policy
- Emergency Preparedness Policy